This application has previously been explored in a variety of cancers, e.g., in human epidermal growth factor receptor 2 (HER2)-positive cancers, where Nbs were employed as vectors for targeted α-particle therapy using both 225Ac and 211At as radionuclides [13,14]. This evidence concerns the gene ERBB2 and cancer.